Gottlieb Joins Pfizer’s Board Of Directors Two Months After Leaving FDA

Former FDA Commissioner Scott Gottlieb is joining the board of directors of Pfizer, which under Gottlieb’s leadership FDA accused of gaming drug patents to impede generic competition. Gottlieb made the announcement via Twitter Thursday (June 27), two weeks after he defended the company’s choice to not investigate signals that its anti-inflammatory drug Enbrel appeared to reduce the risk of Alzheimer’s. He argued drug makers are not obliged to investigate or publish potential treatment signals that researchers encounter. “I’m honored to...